Public Relations Office, AMU
ALIGARH February 1: Dr Kohkan Shamsi (Founder, RadMD LLC, USA, Principal of Blinded Reader and Investigator Training Institute (BRITI), USA, and Adjunct Professor, Department of Radiodiagnosis, Jawaharlal Nehru Medical College, Aligarh Muslim University) delineated fundamentals of drug development and clinical trials with special reference to US-FDA and ICH guidelines. He explained the four phases of CTs and how to submit New Drug Applications (NDA) in Europe, Japan and in the USA.
He was delivering a lecture at JNMC, organized by the Aligs’ Academic Enrichment Programme (AAEP), Aligarh Muslim University, in collaboration with Aligarh Medical Alumni Association of North America (AMAANA).
Dr Kohkan, who has been involved in clinical development and NDA submissions that led to the approvals of 9 MRI, 3 CT contrast agents and 5 radiopharmaceuticals, expressed willingness to contribute to start a centre of excellence for clinical trial at JNMC.
In her lecture, Dr Tazeen Beg (Division Chief, NORA, Stony Brook Medicine, USA), who is also an alumnus of JN Medical College, discussed the relevance and challenges in the development of Non-Operating Room Anaesthesia (NORA).
She focused on the evidence-based strategies related to the safety of patients in the Endoscopy Unit and other NORA areas and shared her experience during the Covid-19 as part of the Airway Team for intubating the Covid patients.
In her presidential remarks, Prof. Veena Maheshwari (Dean, Faculty of Medicine) appreciated the AAEP and AMAANA for organizing such programmes that would help residents and consultants at JNMC.
JNMC Principal and CMS, Prof. Rakesh Bhargava welcomed the guest speakers.
Prof. Syed Ziaur Rahman (Coordinator, AAEP) briefed about the activities of AAEP. Dr. Pragya Hangma conducted the programme and Dr. Anam Alam extended the vote of thanks.
Dr. Shamsi, MD, PhD, co-founder and principal of RadMD is a radiologist with 25+ years of clinical development experience for drugs and devices.
JNMC Year of Graduation: MBBS 1991, MS (General Surgery) 2001
JNMC Year of Graduation: MBBS 1990, MD (Pediatrics) 1993. Won 3 Gold Medals and President of India’s Silver Medal during MBBS.
JNMC Year of Graduation: MBBS 1976, MD (Medicine)1980
JNMC Year of Graduation: MBBS 1992, MD Radiology (1992-95, did not finish, moved to US)
JNMC Year of Graduation: MBBS 1995
JNMC Year of Graduation: MBBS 1996
JNMC Year of Graduation: MBBS 2002, MD (Radiology) 2007
JNMC Year of Graduation: MBBS 2005, MD (Pathology) 2008
JNMC Year of Graduation: MBBS 1991, MD (Anesthesiology) 1994.
Dr. Ashraf Khan received his medical (MBBS) degree in 1980 from Jawaharlal Nehru Medical College, AMU, Aligarh, India following which he did 3-year postgraduate training (MD) in Pathology and then joined as a lecturer in Pathology at the same institution in 1983. In 1985 Dr. Khan moved to England where he trained in Histopathology at Lewisham and Guy’s Hospital of the University of London. This training included experience of working at the Hedley Atkins Breast Unit of the Imperial Cancer Research Foundation at Guy’s Hospital under Dr. Rosemary Millis an internationally recognized breast pathologist who inspired him to become interested in breast pathology. After serving as a senior Registrar in Histopathology for 3 years at Guy’s Hospital and passing the MRCPath examination, Dr. Khan migrated to the United States in 1993 to join as a Surgical Pathology Fellow at University of Massachusetts Medical Center (UMMC). This one-year fellowship was followed by his appointment as an Assistant Professor in Pathology at UMMC in 1994, and worked his way up to his present position as Professor of Pathology (since 2005). He is currently the Director of Surgical Pathology and served as Director of Pathology Residency Program from 2001-08 at the University of Massachusetts Medical School. He is actively involved in the UMASS medical center and medical school administrative functions serving on the Faculty Council, Medical School Admissions Committee, Cancer Committee, and Director of Clinical Labs at UMASS’s Hahnemann and Memorial campuses and Quality Assurance Coordinator of the Hospital Tumor Registry among others.